Markin AM - Search Results

1

Effect of 5-aminolevulinic Acid on Mitochondrial Activity.

Markina YV, Markin AM, Kirichenko TV, Tolstik TV, Cherednichenko VR, Kiseleva DG, Orekhov AN. Markina YV, et al. Among authors: markin am. Front Biosci (Schol Ed). 2023 Dec 27;15(4):17. doi: 10.31083/j.fbs1504017. Front Biosci (Schol Ed). 2023. PMID: 38163956 Free article.

2

Signaling Pathways and Key Genes Involved in Regulation of foam Cell Formation in Atherosclerosis.

Poznyak AV, Wu WK, Melnichenko AA, Wetzker R, Sukhorukov V, Markin AM, Khotina VA, Orekhov AN. Poznyak AV, et al. Among authors: markin am. Cells. 2020 Mar 1;9(3):584. doi: 10.3390/cells9030584. Cells. 2020. PMID: 32121535 Free PMC article. Review.

3

Medicinal Plants as a Potential and Successful Treatment Option in the Context of Atherosclerosis.

Kirichenko TV, Sukhorukov VN, Markin AM, Nikiforov NG, Liu PY, Sobenin IA, Tarasov VV, Orekhov AN, Aliev G. Kirichenko TV, et al. Among authors: markin am. Front Pharmacol. 2020 Apr 8;11:403. doi: 10.3389/fphar.2020.00403. eCollection 2020. Front Pharmacol. 2020. PMID: 32322201 Free PMC article. Review.

4

Cellular Mechanisms of Human Atherogenesis: Focus on Chronification of Inflammation and Mitochondrial Mutations.

Markin AM, Sobenin IA, Grechko AV, Zhang D, Orekhov AN. Markin AM, et al. Front Pharmacol. 2020 May 14;11:642. doi: 10.3389/fphar.2020.00642. eCollection 2020. Front Pharmacol. 2020. PMID: 32528276 Free PMC article. Review.

5

Sialylated Immunoglobulins for the Treatment of Immuno-Inflammatory Diseases.

Markina YV, Gerasimova EV, Markin AM, Glanz VY, Wu WK, Sobenin IA, Orekhov AN. Markina YV, et al. Among authors: markin am. Int J Mol Sci. 2020 Jul 31;21(15):5472. doi: 10.3390/ijms21155472. Int J Mol Sci. 2020. PMID: 32751832 Free PMC article. Review.

6

Genetics of Arterial-Wall-Specific Mechanisms in Atherosclerosis: Focus on Mitochondrial Mutations.

Orekhov AN, Ivanova EA, Markin AM, Nikiforov NG, Sobenin IA. Orekhov AN, et al. Among authors: markin am. Curr Atheroscler Rep. 2020 Aug 9;22(10):54. doi: 10.1007/s11883-020-00873-5. Curr Atheroscler Rep. 2020. PMID: 32772280 Review.

7

Prospects for the Use of Sialidase Inhibitors in Anti-atherosclerotic Therapy.

Sobenin IA, Markin AM, Glanz VY, Markina YV, Wu WK, Myasoedova VA, Orekhov AN. Sobenin IA, et al. Among authors: markin am. Curr Med Chem. 2021 May 4;28(12):2438-2450. doi: 10.2174/0929867327666200831133912. Curr Med Chem. 2021. PMID: 32867633 Review.

8

Mechanistic factors of cardiovascular diseases.

Markin AM, Orekhov AN. Markin AM, et al. Minerva Cardioangiol. 2020 Dec;68(6):599-601. doi: 10.23736/S0026-4725.20.05559-0. Minerva Cardioangiol. 2020. PMID: 33302610 No abstract available.

9

Pro-inflammatory molecules induce cholesterol accumulation in macrophages: Role of inflammatory response in foam cell formation.

Orekhov AN, Markin AM, Sukhorukov VN, Khotina VA, Ivanova E. Orekhov AN, et al. Among authors: markin am. Atherosclerosis. 2021 Mar;320:129-130. doi: 10.1016/j.atherosclerosis.2021.01.007. Epub 2021 Jan 12. Atherosclerosis. 2021. PMID: 33485634 No abstract available.

10

Overview of OxLDL and Its Impact on Cardiovascular Health: Focus on Atherosclerosis.

Poznyak AV, Nikiforov NG, Markin AM, Kashirskikh DA, Myasoedova VA, Gerasimova EV, Orekhov AN. Poznyak AV, et al. Among authors: markin am. Front Pharmacol. 2021 Jan 11;11:613780. doi: 10.3389/fphar.2020.613780. eCollection 2020. Front Pharmacol. 2021. PMID: 33510639 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

29 results

Search Page